{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:21:40Z","timestamp":1767612100786,"version":"3.41.2"},"reference-count":28,"publisher":"Becaris Publishing Limited","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>\n            <jats:bold>Aim:<\/jats:bold>\n            Erectile dysfunction (ED) is marked by a recurring incapacity to achieve or uphold a satisfactory erection during sexual activities. The study aims to increase awareness about male reproductive health, dispel misconceptions about ED and encourage physician-patient discussions.\n            <jats:bold>Materials &amp; methods:<\/jats:bold>\n            A live online poll was conducted during a 3-day webinar titled \u201cTurning the Tide of Men's Health\u201d organized by Viatris\u2122 in collaboration with the Saudi Society of Family and Community Medicine and attended by healthcare professionals (HCPs) from diverse specialties. The attendees voluntarily responded to nine poll questions on adherence to ED medication, use of phosphodiesterase type 5 inhibitors (PDE5is) as cure versus management of ED and patients' challenges. The responses to the poll questions were recorded and assessed to understand the perceptions of HCPs.\n            <jats:bold>Results:<\/jats:bold>\n            The poll garnered 10,423 responses from 5831 attendees on the second day of the webinar. The key findings included HCPs' perceptions that PDE5is contribute to ED management not complete cure. The respondents acknowledged that adherence to ED medications might decline on days without planned sexual activity, and long-term adherence on a daily PDE5i is exhibited by a relatively modest percentage of ED patients. The consensus among respondents was that PDE5is do not enhance or generate sexual desire, and the daily schedule of ED treatment may be burdensome for some patients.\n            <jats:bold>Conclusion:<\/jats:bold>\n            The findings from this poll offer insights into the perspectives of HCPs regarding the usage of PDE5is to treat ED. Responders of the poll generally agreed that PDE5is can help manage ED without affecting desire, though adherence may be lower on days without planned sexual activity. Furthermore, most respondents acknowledged that adhering to a daily pill regimen posed a greater burden than waiting for the medication to take effect.\n          <\/jats:p>","DOI":"10.57264\/cer-2023-0155","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T11:53:27Z","timestamp":1716378807000},"source":"Crossref","is-referenced-by-count":1,"title":["Phosphodiesterase type 5 inhibitors as treatment for erectile dysfunction: a webinar-based poll unveiling perceptions of healthcare professionals"],"prefix":"10.57264","volume":"13","author":[{"given":"Maher S","family":"Moazin","sequence":"first","affiliation":[{"name":"Assistant Professor of Urology, King Saud University for Health Science, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz","family":"Baazeem","sequence":"additional","affiliation":[{"name":"Associate Professor of Urology, Umm Al-Qura University, Makkah, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Al-Bakri","sequence":"additional","affiliation":[{"name":"Urology consultant, Male Reproductive Health specialist, Security Forces Hospital, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel Al","family":"Dayel","sequence":"additional","affiliation":[{"name":"Consultant Urologist\/Andrologist, Director of Men's Health Clinic, Dammam, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Amir","sequence":"additional","affiliation":[{"name":"Consultant Family Medicine, International Medical Center, Jeddah, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saud Al","family":"Sifri","sequence":"additional","affiliation":[{"name":"Consultant Endocrinologist, Department of Endocrinology &amp; Diabetes, Alhada Armed Forces Hospital, Taif, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Reda","sequence":"additional","affiliation":[{"name":"Professor of Psychiatry, Ain Shams University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Bashraheel","sequence":"additional","affiliation":[{"name":"Urologist\/Andrologist, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Alfakhri","sequence":"additional","affiliation":[{"name":"Consultant Andrology\/Male Infertility, King Fahad Medical City \u2013 Main Hospital, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Hamdy","sequence":"additional","affiliation":[{"name":"Medical Advisor, Viatris, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fayez","family":"Elshaer","sequence":"additional","affiliation":[{"name":"Professor of Cardiology, King Fahad cardiac center, King Khaled university hospital, King Saud university, Riyadh, Saudi Arabia- National heart institute, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"36897","reference":[{"key":"e_1_3_8_3_2","doi-asserted-by":"crossref","first-page":"1148834","DOI":"10.3389\/fendo.2023.1148834","article-title":"Management of male erectile dysfunction: from the past to the future","volume":"14","author":"Wang CM","year":"2023","unstructured":"Wang CM, Wu BR, Xiang P, Xiao J, Hu XC. Management of male erectile dysfunction: from the past to the future. Front. Endocrinol. (Lausanne). 14, 1148834 (2023).","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"e_1_3_8_4_2","doi-asserted-by":"crossref","first-page":"107493","DOI":"10.1016\/j.pharmthera.2020.107493","article-title":"Pharmacology and perspectives in erectile dysfunction in man","volume":"208","author":"Mitidieri E","year":"2020","unstructured":"Mitidieri E, Cirino G, d'Emmanuele di Villa Bianca R, Sorrentino R. Pharmacology and perspectives in erectile dysfunction in man. Pharmacol. Ther. 208, 107493 (2020).","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"e_1_3_8_5_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/26318318231158246","article-title":"Psychosexual health and sexuality: multidisciplinary considerations in clinical practice","volume":"5","author":"Tandon A","year":"2023","unstructured":"Tandon A. Psychosexual health and sexuality: multidisciplinary considerations in clinical practice. J. Psychosexual Health. 5(2), 106\u2013113 (2023).","journal-title":"J. Psychosexual Health."},{"issue":"5","key":"e_1_3_8_6_2","first-page":"100436","article-title":"Psychological distress in erectile dysfunction: the moderating role of attachment","volume":"9","author":"Maestre-Lor\u00e9n F","year":"2021","unstructured":"Maestre-Lor\u00e9n F, Castillo-Garayoa JA, L\u00f3pez-i-Mart\u00edn X, Sarquella-Geli J, Andr\u00e9s A, Cifre I. Psychological distress in erectile dysfunction: the moderating role of attachment. Sex. Med. 9(5), 100436 (2021).","journal-title":"Sex. Med."},{"issue":"7","key":"e_1_3_8_7_2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/medicina59071195","article-title":"An evaluation of psychogenic predictors of non-organic erectile dysfunction","volume":"59","author":"Topak OZ","year":"2023","unstructured":"Topak OZ, Sinik Z, Oguzhanoglu NK, Ugurlu TT. An evaluation of psychogenic predictors of non-organic erectile dysfunction. Medicina. (Kaunas). 59(7), 1195 (2023).","journal-title":"Medicina. (Kaunas)."},{"issue":"1","key":"e_1_3_8_8_2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.dsx.2018.11.052","article-title":"Dyslipidaemia as a risk factor for erectile dysfunction in Type 2 diabetes mellitus patients","volume":"13","author":"Azad AK","year":"2019","unstructured":"Azad AK, Setunge S, Selim S Dyslipidaemia as a risk factor for erectile dysfunction in Type 2 diabetes mellitus patients. Diabetes Metab. Syndr. 13(1), 748\u2013753 (2019).","journal-title":"Diabetes Metab. Syndr."},{"issue":"2","key":"e_1_3_8_9_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.aju.2012.01.004","article-title":"Erectile dysfunction in Arab countries. Part I: prevalence and correlates","volume":"10","author":"El-Sakka AI","year":"2012","unstructured":"El-Sakka AI. Erectile dysfunction in Arab countries. Part I: prevalence and correlates. Arab J. Urol. 10(2), 97\u2013103 (2012).","journal-title":"Arab J. Urol."},{"issue":"2","key":"e_1_3_8_10_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41443-018-0067-x","article-title":"Sildenafil's impact on male infertility: what has changed in 20 years?","volume":"31","author":"Scherzer ND","year":"2019","unstructured":"Scherzer ND, Le TV, Hellstrom WJG. Sildenafil's impact on male infertility: what has changed in 20 years? Int. J. Impot. Res. 31(2), 71\u201373 (2019).","journal-title":"Int. J. Impot. Res."},{"issue":"5","key":"e_1_3_8_11_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41443-018-0046-2","article-title":"Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil","volume":"30","author":"Moncada I","year":"2018","unstructured":"Moncada I, Martinez-Salamanca J, Ruiz-Casta\u00f1e E, Romero J. Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil. Int. J. Impot. Res. 30(5), 203\u2013208 (2018).","journal-title":"Int. J. Impot. Res."},{"issue":"6","key":"e_1_3_8_12_2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/cpt.261","article-title":"Pharmacotherapeutic management of erectile dysfunction","volume":"98","author":"Hawksworth DJ","year":"2015","unstructured":"Hawksworth DJ, Burnett AL. Pharmacotherapeutic management of erectile dysfunction. Clin. Pharmacol. Ther. 98(6), 602\u2013610 (2015).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"e_1_3_8_13_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1464-410X.2005.05614.x","article-title":"Phosphodiesterase type 5 inhibitors for erectile dysfunction","volume":"96","author":"Carson CC","year":"2005","unstructured":"Carson CC, Lue TF. Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int. 96(3), 257\u2013280 (2005).","journal-title":"BJU Int."},{"key":"e_1_3_8_14_2","volume-title":"In The EAU Annual Congress Milan","author":"Salonia ABC","year":"2023","unstructured":"Salonia ABC, Capogrosso P, Carvalho J; EAU Guidelines In The EAU Annual Congress Milan. EAU Guidelines Office, Arnhem, The Netherlands (2023). Available at: https:\/\/uroweb.org\/guidelines\/sexual-and-reproductive-health"},{"issue":"6","key":"e_1_3_8_15_2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s40618-023-02015-5","article-title":"The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of erectile dysfunction","volume":"46","author":"Corona G","year":"2023","unstructured":"Corona G, Cucinotta D, Di Lorenzo G The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of erectile dysfunction. J.Endocrinol. Invest. 46(6), 1241\u20131274 (2023). doi:10.1007\/s40618-023-02015-5","journal-title":"J.Endocrinol. Invest."},{"issue":"24","key":"e_1_3_8_16_2","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","article-title":"Erectile dysfunction","volume":"342","author":"Lue TF","year":"2000","unstructured":"Lue TF. Erectile dysfunction. N. Engl. J. Med. 342(24), 1802\u20131813 (2000).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"e_1_3_8_17_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.eururo.2004.09.005","article-title":"Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis","volume":"47","author":"Behr-Roussel D","year":"2005","unstructured":"Behr-Roussel D, Gorny D, Mevel K Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis. Eur. Urol. 47(1), 87\u201391 (2005).","journal-title":"Eur. Urol."},{"issue":"2","key":"e_1_3_8_18_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1464-410X.2007.07223.x","article-title":"Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection","volume":"101","author":"Kovanecz I","year":"2008","unstructured":"Kovanecz I, Rambhatla A, Ferrini MG Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int. 101(2), 203\u2013210 (2008).","journal-title":"BJU Int."},{"issue":"1","key":"e_1_3_8_19_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.esxm.2018.11.008","article-title":"Endothelial dysfunction in patients with erectile dysfunction: a double-blind, randomized-control trial using tadalafil","volume":"7","author":"Pattanaik S","year":"2019","unstructured":"Pattanaik S, Kaundal P, Mavuduru RS, Singh SK, Mandal AK. Endothelial dysfunction in patients with erectile dysfunction: a double-blind, randomized-control trial using tadalafil. Sex Med. 7(1), 41\u201347 (2019).","journal-title":"Sex Med."},{"issue":"2","key":"e_1_3_8_20_2","doi-asserted-by":"crossref","first-page":"e13296","DOI":"10.1111\/ijcp.13296","article-title":"Effect of prolonged treatment with phosphodiesterase-5-inhibitors on endothelial dysfunction in vascular diseases and vascular risk conditions: a systematic review analysis and meta-analysis of randomized double-blind placebo-controlled trials","volume":"73","author":"D'Andrea S","year":"2019","unstructured":"D'Andrea S, Barbonetti A, Martorella A, Necozione S, Francavilla F, Francavilla S. Effect of prolonged treatment with phosphodiesterase-5-inhibitors on endothelial dysfunction in vascular diseases and vascular risk conditions: a systematic review analysis and meta-analysis of randomized double-blind placebo-controlled trials. Int. J. Clin. Pract. 73(2), e13296 (2019).","journal-title":"Int. J. Clin. Pract."},{"issue":"9","key":"e_1_3_8_21_2","doi-asserted-by":"crossref","first-page":"254725","DOI":"10.1111\/j.1743-6109.2009.01375.x","article-title":"The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction","volume":"6","author":"Jannini EA","year":"2009","unstructured":"Jannini EA, Isidori AM, Gravina GL The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction. J. Sex. Med. 6(9), 254725\u2013254760 (2009).","journal-title":"J. Sex. Med."},{"issue":"9","key":"e_1_3_8_22_2","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1743-6109.2012.02787.x","article-title":"Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation","volume":"9","author":"Carvalheira AA","year":"2012","unstructured":"Carvalheira AA, Pereira NM, Maroco J Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation. J. Sex. Med. 9(9), 2361\u20132369 (2012).","journal-title":"J. Sex. Med."},{"issue":"3","key":"e_1_3_8_23_2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2125.2005.02553.x","article-title":"Tadalafil pharmacokinetics in healthy subjects","volume":"61","author":"Forgue ST","year":"2006","unstructured":"Forgue ST, Patterson BE, Bedding AW Tadalafil pharmacokinetics in healthy subjects. Br. J. Clin. Pharmacol. 61(3), 280\u2013288 (2006).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"8","key":"e_1_3_8_24_2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/ijcp.12074","article-title":"PDE5 inhibitors: considerations for preference and long-term adherence","volume":"67","author":"Smith WB","year":"2013","unstructured":"Smith WB 2nd, McCaslin IR, Gokce A, Mandava SH, Trost L, Hellstrom WJ. PDE5 inhibitors: considerations for preference and long-term adherence. Int. J. Clin. Pract. 67(8), 768\u2013780 (2013).","journal-title":"Int. J. Clin. Pract."},{"issue":"2","key":"e_1_3_8_25_2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/sm2.31","article-title":"Adherence to phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction in long-term users: how do men use the inhibitors?","volume":"2","author":"Carvalheira A","year":"2014","unstructured":"Carvalheira A, Forjaz V, Pereira NM. Adherence to phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction in long-term users: how do men use the inhibitors? Sex. Med. 2(2), 96\u2013102 (2014).","journal-title":"Sex. Med."},{"issue":"4","key":"e_1_3_8_26_2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ucl.2021.06.009","article-title":"Physiology of erection and pathophysiology of erectile dysfunction","volume":"48","author":"MacDonald SM","year":"2021","unstructured":"MacDonald SM, Burnett AL. Physiology of erection and pathophysiology of erectile dysfunction. Urol. Clin. North Am. 48(4), 513\u2013525 (2021).","journal-title":"Urol. Clin. North Am."},{"issue":"17","key":"e_1_3_8_27_2","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1001\/jama.2016.12284","article-title":"Erectile dysfunction","volume":"316","author":"Najari BB","year":"2016","unstructured":"Najari BB, Kashanian JA. Erectile dysfunction. JAMA 316(17), 1838 (2016).","journal-title":"JAMA"},{"issue":"4","key":"e_1_3_8_28_2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1948550615616462","article-title":"Sexual frequency predicts greater well-being, but more is not always better","volume":"7","author":"Muise A","year":"2016","unstructured":"Muise A, Schimmack U, Impett EA. Sexual frequency predicts greater well-being, but more is not always better. Soc. Psychol. Pers. Sci. 7(4), 295\u2013302 (2016).","journal-title":"Soc. Psychol. Pers. Sci."},{"issue":"3","key":"e_1_3_8_29_2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.esxm.2020.05.001","article-title":"Real-world assessment of the impact of erectile dysfunction on sexual planning behavior and health- and treatment-related outcomes among men in 8 countries","volume":"8","author":"Goldstein I","year":"2020","unstructured":"Goldstein I, Giraldi A, Maculaitis MC, Li VW, Hartzell-Cushanick R, Hassan TA. Real-world assessment of the impact of erectile dysfunction on sexual planning behavior and health- and treatment-related outcomes among men in 8 countries. Sex Med. 8(3), 338\u2013349 (2020).","journal-title":"Sex Med."},{"issue":"4","key":"e_1_3_8_30_2","doi-asserted-by":"crossref","first-page":"e13074","DOI":"10.1111\/ijcp.13074","article-title":"Sexual habits of men with ED who take phosphodiesterase 5 inhibitors: a survey conducted in 7 countries","volume":"72","author":"Mulhall JP","year":"2018","unstructured":"Mulhall JP, Hassan TA, Rienow J. Sexual habits of men with ED who take phosphodiesterase 5 inhibitors: a survey conducted in 7 countries. Int J Clin Pract. 72(4), e13074 (2018).","journal-title":"Int J Clin Pract."}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.57264\/cer-2023-0155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T11:16:36Z","timestamp":1720091796000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.57264\/cer-2023-0155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.57264\/cer-2023-0155"],"URL":"https:\/\/doi.org\/10.57264\/cer-2023-0155","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"type":"print","value":"2042-6305"},{"type":"electronic","value":"2042-6313"}],"subject":[],"published":{"date-parts":[[2024,7]]},"article-number":"e230155"}}